nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—CYP2D6—Carteolol—glaucoma	0.0854	0.17	CbGbCtD
Vinorelbine—CYP2D6—Betaxolol—glaucoma	0.0577	0.115	CbGbCtD
Vinorelbine—CYP2D6—Methazolamide—glaucoma	0.0437	0.0869	CbGbCtD
Vinorelbine—CYP3A4—Pilocarpine—glaucoma	0.0411	0.0818	CbGbCtD
Vinorelbine—ABCB1—Timolol—glaucoma	0.0394	0.0784	CbGbCtD
Vinorelbine—CYP2D6—Timolol—glaucoma	0.0372	0.0738	CbGbCtD
Vinorelbine—ABCB1—Clonidine—glaucoma	0.0335	0.0666	CbGbCtD
Vinorelbine—CYP3A4—Brinzolamide—glaucoma	0.0323	0.0642	CbGbCtD
Vinorelbine—CYP2D6—Clonidine—glaucoma	0.0316	0.0628	CbGbCtD
Vinorelbine—CYP3A4—Dorzolamide—glaucoma	0.0312	0.062	CbGbCtD
Vinorelbine—CYP3A4—Methazolamide—glaucoma	0.0278	0.0552	CbGbCtD
Vinorelbine—CYP3A4—Acetazolamide—glaucoma	0.0222	0.0442	CbGbCtD
Vinorelbine—CYP3A4—Clonidine—glaucoma	0.0201	0.0399	CbGbCtD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00192	0.0177	CbGpPWpGaD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00187	0.0173	CbGpPWpGaD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.00184	0.017	CbGpPWpGaD
Vinorelbine—TUBB4B—Loss of Nlp from mitotic centrosomes—FGFR1OP—glaucoma	0.00183	0.0169	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00181	0.0167	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00177	0.0164	CbGpPWpGaD
Vinorelbine—TUBB4A—Centrosome maturation—FGFR1OP—glaucoma	0.00177	0.0163	CbGpPWpGaD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—FGFR1OP—glaucoma	0.00162	0.015	CbGpPWpGaD
Vinorelbine—TUBB4B—Centrosome maturation—FGFR1OP—glaucoma	0.00162	0.0149	CbGpPWpGaD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.0016	0.0148	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00159	0.0147	CbGpPWpGaD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.00153	0.0141	CbGpPWpGaD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—FGFR1OP—glaucoma	0.00148	0.0137	CbGpPWpGaD
Vinorelbine—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00147	0.0136	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—FGFR1OP—glaucoma	0.00147	0.0136	CbGpPWpGaD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—NCK2—glaucoma	0.00146	0.0134	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.00145	0.0134	CbGpPWpGaD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—RAB8A—glaucoma	0.0014	0.0129	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—RAB8A—glaucoma	0.00138	0.0128	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.00136	0.0126	CbGpPWpGaD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.00132	0.0122	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—FGFR1OP—glaucoma	0.00122	0.0113	CbGpPWpGaD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—OPTN—glaucoma	0.00121	0.0112	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.0012	0.0111	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—OPTN—glaucoma	0.0012	0.0111	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—OPTN—glaucoma	0.00118	0.0109	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—RAB8A—glaucoma	0.00115	0.0106	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.00113	0.0104	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—FGFR1OP—glaucoma	0.00111	0.0103	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—FGFR1OP—glaucoma	0.0011	0.0102	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—RAB8A—glaucoma	0.00105	0.00968	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—RAB8A—glaucoma	0.00103	0.00955	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—OPTN—glaucoma	0.000993	0.00918	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—OPTN—glaucoma	0.00098	0.00905	CbGpPWpGaD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class II—NR3C1—glaucoma	0.000978	0.00903	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—OPTN—glaucoma	0.000909	0.0084	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—OPTN—glaucoma	0.000896	0.00828	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000674	0.00623	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—PEX19—glaucoma	0.000674	0.00623	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000651	0.00602	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—PEX19—glaucoma	0.000631	0.00583	CbGpPWpGaD
Vinorelbine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000629	0.00581	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000617	0.0057	CbGpPWpGaD
Vinorelbine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000615	0.00568	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—PEX19—glaucoma	0.000554	0.00512	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—DHPS—glaucoma	0.000546	0.00505	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—DHPS—glaucoma	0.000546	0.00505	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—DHPS—glaucoma	0.000527	0.00487	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—DHPS—glaucoma	0.000511	0.00472	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—PEX19—glaucoma	0.000506	0.00468	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—DHPS—glaucoma	0.000499	0.00461	CbGpPWpGaD
Vinorelbine—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000488	0.00451	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000468	0.00432	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000455	0.00421	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000455	0.00421	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—DHPS—glaucoma	0.000448	0.00414	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RAB8A—glaucoma	0.00044	0.00406	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00044	0.00406	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000426	0.00394	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—FGFR1OP—glaucoma	0.000418	0.00387	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000416	0.00385	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—DHPS—glaucoma	0.00041	0.00379	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RAB8A—glaucoma	0.000393	0.00363	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000388	0.00358	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000388	0.00358	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—OPTN—glaucoma	0.000381	0.00352	CbGpPWpGaD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000377	0.00349	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000374	0.00346	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000364	0.00337	CbGpPWpGaD
Vinorelbine—Fatigue—Brimonidine—glaucoma	0.000364	0.000936	CcSEcCtD
Vinorelbine—Anorexia—Pilocarpine—glaucoma	0.000363	0.000934	CcSEcCtD
Vinorelbine—Feeling abnormal—Acetazolamide—glaucoma	0.000362	0.000932	CcSEcCtD
Vinorelbine—Hypersensitivity—Apraclonidine—glaucoma	0.000362	0.000932	CcSEcCtD
Vinorelbine—Paraesthesia—Dorzolamide—glaucoma	0.000362	0.000931	CcSEcCtD
Vinorelbine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000361	0.00334	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000361	0.000929	CcSEcCtD
Vinorelbine—Pain—Brimonidine—glaucoma	0.000361	0.000929	CcSEcCtD
Vinorelbine—Dyspnoea—Dorzolamide—glaucoma	0.000359	0.000925	CcSEcCtD
Vinorelbine—Dyspnoea—Travoprost—glaucoma	0.000358	0.000921	CcSEcCtD
Vinorelbine—Hypotension—Pilocarpine—glaucoma	0.000356	0.000916	CcSEcCtD
Vinorelbine—Paraesthesia—Brinzolamide—glaucoma	0.000356	0.000915	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000355	0.00328	CbGpPWpGaD
Vinorelbine—Dyspnoea—Brinzolamide—glaucoma	0.000353	0.000909	CcSEcCtD
Vinorelbine—Asthenia—Apraclonidine—glaucoma	0.000353	0.000907	CcSEcCtD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000352	0.00326	CbGpPWpGaD
Vinorelbine—Decreased appetite—Dorzolamide—glaucoma	0.00035	0.000901	CcSEcCtD
Vinorelbine—Urticaria—Acetazolamide—glaucoma	0.000349	0.000899	CcSEcCtD
Vinorelbine—Pruritus—Apraclonidine—glaucoma	0.000348	0.000895	CcSEcCtD
Vinorelbine—Body temperature increased—Acetazolamide—glaucoma	0.000347	0.000894	CcSEcCtD
Vinorelbine—Fatigue—Dorzolamide—glaucoma	0.000347	0.000894	CcSEcCtD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—glaucoma	0.000347	0.00321	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000347	0.000893	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—FGFR1OP—glaucoma	0.000347	0.0032	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Travoprost—glaucoma	0.000346	0.000891	CcSEcCtD
Vinorelbine—Fatigue—Travoprost—glaucoma	0.000346	0.00089	CcSEcCtD
Vinorelbine—Flushing—Betaxolol—glaucoma	0.000346	0.00089	CcSEcCtD
Vinorelbine—Cardiac disorder—Betaxolol—glaucoma	0.000346	0.00089	CcSEcCtD
Vinorelbine—Ill-defined disorder—Clonidine—glaucoma	0.000346	0.00089	CcSEcCtD
Vinorelbine—Pain—Dorzolamide—glaucoma	0.000345	0.000887	CcSEcCtD
Vinorelbine—Decreased appetite—Brinzolamide—glaucoma	0.000344	0.000886	CcSEcCtD
Vinorelbine—Weight decreased—Timolol—glaucoma	0.000344	0.000885	CcSEcCtD
Vinorelbine—Pain—Travoprost—glaucoma	0.000343	0.000883	CcSEcCtD
Vinorelbine—Constipation—Travoprost—glaucoma	0.000343	0.000883	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000342	0.00316	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000342	0.00088	CcSEcCtD
Vinorelbine—Paraesthesia—Pilocarpine—glaucoma	0.000342	0.00088	CcSEcCtD
Vinorelbine—Asthenia—Bimatoprost—glaucoma	0.000342	0.00088	CcSEcCtD
Vinorelbine—Fatigue—Brinzolamide—glaucoma	0.000342	0.000879	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—OPTN—glaucoma	0.000341	0.00315	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CTSA—glaucoma	0.000341	0.00315	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CTSA—glaucoma	0.000341	0.00315	CbGpPWpGaD
Vinorelbine—Angioedema—Clonidine—glaucoma	0.00034	0.000876	CcSEcCtD
Vinorelbine—Dyspnoea—Pilocarpine—glaucoma	0.000339	0.000874	CcSEcCtD
Vinorelbine—Pain—Brinzolamide—glaucoma	0.000339	0.000872	CcSEcCtD
Vinorelbine—Angiopathy—Betaxolol—glaucoma	0.000338	0.00087	CcSEcCtD
Vinorelbine—Pruritus—Bimatoprost—glaucoma	0.000337	0.000868	CcSEcCtD
Vinorelbine—Immune system disorder—Betaxolol—glaucoma	0.000337	0.000866	CcSEcCtD
Vinorelbine—Diarrhoea—Apraclonidine—glaucoma	0.000336	0.000865	CcSEcCtD
Vinorelbine—Malaise—Clonidine—glaucoma	0.000336	0.000865	CcSEcCtD
Vinorelbine—Mediastinal disorder—Betaxolol—glaucoma	0.000336	0.000864	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000333	0.00308	CbGpPWpGaD
Vinorelbine—Arrhythmia—Betaxolol—glaucoma	0.000333	0.000857	CcSEcCtD
Vinorelbine—Feeling abnormal—Dorzolamide—glaucoma	0.000332	0.000855	CcSEcCtD
Vinorelbine—Decreased appetite—Pilocarpine—glaucoma	0.000331	0.000852	CcSEcCtD
Vinorelbine—Feeling abnormal—Travoprost—glaucoma	0.000331	0.000851	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000329	0.000848	CcSEcCtD
Vinorelbine—Alopecia—Betaxolol—glaucoma	0.000329	0.000847	CcSEcCtD
Vinorelbine—Palpitations—Clonidine—glaucoma	0.000329	0.000847	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—CTSA—glaucoma	0.000329	0.00304	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000329	0.000846	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Travoprost—glaucoma	0.000328	0.000844	CcSEcCtD
Vinorelbine—Feeling abnormal—Brinzolamide—glaucoma	0.000326	0.00084	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—RAB8A—glaucoma	0.000326	0.00301	CbGpPWpGaD
Vinorelbine—Pain—Pilocarpine—glaucoma	0.000326	0.000838	CcSEcCtD
Vinorelbine—Constipation—Pilocarpine—glaucoma	0.000326	0.000838	CcSEcCtD
Vinorelbine—Cough—Clonidine—glaucoma	0.000325	0.000837	CcSEcCtD
Vinorelbine—Dizziness—Apraclonidine—glaucoma	0.000325	0.000836	CcSEcCtD
Vinorelbine—Erythema—Betaxolol—glaucoma	0.000324	0.000835	CcSEcCtD
Vinorelbine—Malnutrition—Betaxolol—glaucoma	0.000324	0.000835	CcSEcCtD
Vinorelbine—Urticaria—Dorzolamide—glaucoma	0.00032	0.000824	CcSEcCtD
Vinorelbine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000319	0.00295	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CTSA—glaucoma	0.000319	0.00295	CbGpPWpGaD
Vinorelbine—Body temperature increased—Dorzolamide—glaucoma	0.000319	0.00082	CcSEcCtD
Vinorelbine—Abdominal pain—Dorzolamide—glaucoma	0.000319	0.00082	CcSEcCtD
Vinorelbine—Chest pain—Clonidine—glaucoma	0.000317	0.000816	CcSEcCtD
Vinorelbine—Arthralgia—Clonidine—glaucoma	0.000317	0.000816	CcSEcCtD
Vinorelbine—Abdominal pain—Travoprost—glaucoma	0.000317	0.000816	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—FGFR1OP—glaucoma	0.000317	0.00293	CbGpPWpGaD
Vinorelbine—Agranulocytosis—Timolol—glaucoma	0.000316	0.000814	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000316	0.00292	CbGpPWpGaD
Vinorelbine—Asthenia—Acetazolamide—glaucoma	0.000315	0.000812	CcSEcCtD
Vinorelbine—Dizziness—Bimatoprost—glaucoma	0.000315	0.000811	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000315	0.000811	CcSEcCtD
Vinorelbine—Urticaria—Brinzolamide—glaucoma	0.000315	0.00081	CcSEcCtD
Vinorelbine—Feeling abnormal—Pilocarpine—glaucoma	0.000314	0.000807	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—ACE2—glaucoma	0.000314	0.0029	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—ACE2—glaucoma	0.000314	0.0029	CbGpPWpGaD
Vinorelbine—Discomfort—Clonidine—glaucoma	0.000313	0.000807	CcSEcCtD
Vinorelbine—Vomiting—Apraclonidine—glaucoma	0.000312	0.000804	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—CTSA—glaucoma	0.000312	0.00288	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000311	0.000801	CcSEcCtD
Vinorelbine—Hypersensitivity—Brimonidine—glaucoma	0.000311	0.0008	CcSEcCtD
Vinorelbine—Dermatitis—Apraclonidine—glaucoma	0.00031	0.000797	CcSEcCtD
Vinorelbine—Headache—Apraclonidine—glaucoma	0.000308	0.000792	CcSEcCtD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000305	0.00282	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000304	0.00281	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000304	0.00281	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—ACE2—glaucoma	0.000303	0.0028	CbGpPWpGaD
Vinorelbine—Asthenia—Brimonidine—glaucoma	0.000303	0.000779	CcSEcCtD
Vinorelbine—Infection—Clonidine—glaucoma	0.000302	0.000777	CcSEcCtD
Vinorelbine—Abdominal pain—Pilocarpine—glaucoma	0.000301	0.000775	CcSEcCtD
Vinorelbine—Body temperature increased—Pilocarpine—glaucoma	0.000301	0.000775	CcSEcCtD
Vinorelbine—Ill-defined disorder—Betaxolol—glaucoma	0.000301	0.000775	CcSEcCtD
Vinorelbine—Diarrhoea—Acetazolamide—glaucoma	0.000301	0.000774	CcSEcCtD
Vinorelbine—Rash—Bimatoprost—glaucoma	0.0003	0.000773	CcSEcCtD
Vinorelbine—Dermatitis—Bimatoprost—glaucoma	0.0003	0.000772	CcSEcCtD
Vinorelbine—Anaemia—Betaxolol—glaucoma	0.0003	0.000772	CcSEcCtD
Vinorelbine—Connective tissue disorder—Timolol—glaucoma	0.000299	0.00077	CcSEcCtD
Vinorelbine—Pruritus—Brimonidine—glaucoma	0.000298	0.000768	CcSEcCtD
Vinorelbine—Headache—Bimatoprost—glaucoma	0.000298	0.000768	CcSEcCtD
Vinorelbine—Nervous system disorder—Clonidine—glaucoma	0.000298	0.000767	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—RAB8A—glaucoma	0.000298	0.00275	CbGpPWpGaD
Vinorelbine—Thrombocytopenia—Clonidine—glaucoma	0.000298	0.000766	CcSEcCtD
Vinorelbine—Hypersensitivity—Dorzolamide—glaucoma	0.000297	0.000764	CcSEcCtD
Vinorelbine—Tachycardia—Clonidine—glaucoma	0.000297	0.000764	CcSEcCtD
Vinorelbine—Hypersensitivity—Travoprost—glaucoma	0.000296	0.000761	CcSEcCtD
Vinorelbine—Skin disorder—Clonidine—glaucoma	0.000295	0.00076	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000293	0.00271	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—ACE2—glaucoma	0.000293	0.00271	CbGpPWpGaD
Vinorelbine—Malaise—Betaxolol—glaucoma	0.000292	0.000753	CcSEcCtD
Vinorelbine—Nausea—Apraclonidine—glaucoma	0.000292	0.000751	CcSEcCtD
Vinorelbine—Hypersensitivity—Brinzolamide—glaucoma	0.000292	0.000751	CcSEcCtD
Vinorelbine—Vertigo—Betaxolol—glaucoma	0.000291	0.00075	CcSEcCtD
Vinorelbine—Dizziness—Acetazolamide—glaucoma	0.000291	0.000748	CcSEcCtD
Vinorelbine—Anorexia—Clonidine—glaucoma	0.00029	0.000746	CcSEcCtD
Vinorelbine—Asthenia—Dorzolamide—glaucoma	0.000289	0.000744	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—OPTN—glaucoma	0.000289	0.00267	CbGpPWpGaD
Vinorelbine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000289	0.00267	CbGpPWpGaD
Vinorelbine—Asthenia—Travoprost—glaucoma	0.000288	0.000741	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—ACE2—glaucoma	0.000287	0.00265	CbGpPWpGaD
Vinorelbine—Palpitations—Betaxolol—glaucoma	0.000287	0.000738	CcSEcCtD
Vinorelbine—Pruritus—Dorzolamide—glaucoma	0.000285	0.000734	CcSEcCtD
Vinorelbine—Asthenia—Brinzolamide—glaucoma	0.000284	0.000731	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000284	0.00263	CbGpPWpGaD
Vinorelbine—Hypotension—Clonidine—glaucoma	0.000284	0.000731	CcSEcCtD
Vinorelbine—Pruritus—Travoprost—glaucoma	0.000284	0.000731	CcSEcCtD
Vinorelbine—Cough—Betaxolol—glaucoma	0.000283	0.000728	CcSEcCtD
Vinorelbine—Nausea—Bimatoprost—glaucoma	0.000283	0.000728	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—OPTN—glaucoma	0.000283	0.00261	CbGpPWpGaD
Vinorelbine—Cardiac disorder—Timolol—glaucoma	0.000282	0.000727	CcSEcCtD
Vinorelbine—Hypersensitivity—Pilocarpine—glaucoma	0.00028	0.000722	CcSEcCtD
Vinorelbine—Pruritus—Brinzolamide—glaucoma	0.00028	0.000721	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—CTSA—glaucoma	0.00028	0.00259	CbGpPWpGaD
Vinorelbine—Vomiting—Acetazolamide—glaucoma	0.000279	0.000719	CcSEcCtD
Vinorelbine—Dizziness—Brimonidine—glaucoma	0.000279	0.000718	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000278	0.00257	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000277	0.000713	CcSEcCtD
Vinorelbine—Angiopathy—Timolol—glaucoma	0.000276	0.000711	CcSEcCtD
Vinorelbine—Arthralgia—Betaxolol—glaucoma	0.000276	0.000711	CcSEcCtD
Vinorelbine—Chest pain—Betaxolol—glaucoma	0.000276	0.000711	CcSEcCtD
Vinorelbine—Myalgia—Betaxolol—glaucoma	0.000276	0.000711	CcSEcCtD
Vinorelbine—Diarrhoea—Dorzolamide—glaucoma	0.000276	0.00071	CcSEcCtD
Vinorelbine—Headache—Acetazolamide—glaucoma	0.000275	0.000709	CcSEcCtD
Vinorelbine—Immune system disorder—Timolol—glaucoma	0.000275	0.000708	CcSEcCtD
Vinorelbine—Diarrhoea—Travoprost—glaucoma	0.000274	0.000706	CcSEcCtD
Vinorelbine—Mediastinal disorder—Timolol—glaucoma	0.000274	0.000706	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000274	0.000706	CcSEcCtD
Vinorelbine—Asthenia—Pilocarpine—glaucoma	0.000273	0.000703	CcSEcCtD
Vinorelbine—Paraesthesia—Clonidine—glaucoma	0.000273	0.000703	CcSEcCtD
Vinorelbine—Discomfort—Betaxolol—glaucoma	0.000273	0.000702	CcSEcCtD
Vinorelbine—Arrhythmia—Timolol—glaucoma	0.000272	0.0007	CcSEcCtD
Vinorelbine—Dyspnoea—Clonidine—glaucoma	0.000271	0.000698	CcSEcCtD
Vinorelbine—Diarrhoea—Brinzolamide—glaucoma	0.000271	0.000698	CcSEcCtD
Vinorelbine—Pruritus—Pilocarpine—glaucoma	0.000269	0.000693	CcSEcCtD
Vinorelbine—Alopecia—Timolol—glaucoma	0.000269	0.000692	CcSEcCtD
Vinorelbine—Dizziness—Dorzolamide—glaucoma	0.000266	0.000686	CcSEcCtD
Vinorelbine—Rash—Brimonidine—glaucoma	0.000266	0.000685	CcSEcCtD
Vinorelbine—Dermatitis—Brimonidine—glaucoma	0.000266	0.000684	CcSEcCtD
Vinorelbine—Dizziness—Travoprost—glaucoma	0.000265	0.000683	CcSEcCtD
Vinorelbine—Erythema—Timolol—glaucoma	0.000265	0.000682	CcSEcCtD
Vinorelbine—Malnutrition—Timolol—glaucoma	0.000265	0.000682	CcSEcCtD
Vinorelbine—Headache—Brimonidine—glaucoma	0.000264	0.00068	CcSEcCtD
Vinorelbine—Decreased appetite—Clonidine—glaucoma	0.000264	0.00068	CcSEcCtD
Vinorelbine—Infection—Betaxolol—glaucoma	0.000263	0.000677	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Clonidine—glaucoma	0.000262	0.000676	CcSEcCtD
Vinorelbine—Fatigue—Clonidine—glaucoma	0.000262	0.000675	CcSEcCtD
Vinorelbine—Dizziness—Brinzolamide—glaucoma	0.000262	0.000674	CcSEcCtD
Vinorelbine—Nausea—Acetazolamide—glaucoma	0.000261	0.000672	CcSEcCtD
Vinorelbine—Diarrhoea—Pilocarpine—glaucoma	0.00026	0.00067	CcSEcCtD
Vinorelbine—Pain—Clonidine—glaucoma	0.00026	0.000669	CcSEcCtD
Vinorelbine—Constipation—Clonidine—glaucoma	0.00026	0.000669	CcSEcCtD
Vinorelbine—Nervous system disorder—Betaxolol—glaucoma	0.00026	0.000668	CcSEcCtD
Vinorelbine—Thrombocytopenia—Betaxolol—glaucoma	0.000259	0.000667	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—OPTN—glaucoma	0.000258	0.00239	CbGpPWpGaD
Vinorelbine—Tachycardia—Betaxolol—glaucoma	0.000258	0.000665	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—ACE2—glaucoma	0.000258	0.00238	CbGpPWpGaD
Vinorelbine—Skin disorder—Betaxolol—glaucoma	0.000257	0.000662	CcSEcCtD
Vinorelbine—Vomiting—Dorzolamide—glaucoma	0.000256	0.000659	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—CTSA—glaucoma	0.000256	0.00236	CbGpPWpGaD
Vinorelbine—Rash—Dorzolamide—glaucoma	0.000254	0.000654	CcSEcCtD
Vinorelbine—Dermatitis—Dorzolamide—glaucoma	0.000254	0.000653	CcSEcCtD
Vinorelbine—Rash—Travoprost—glaucoma	0.000253	0.000651	CcSEcCtD
Vinorelbine—Dermatitis—Travoprost—glaucoma	0.000253	0.00065	CcSEcCtD
Vinorelbine—Headache—Dorzolamide—glaucoma	0.000252	0.00065	CcSEcCtD
Vinorelbine—Anorexia—Betaxolol—glaucoma	0.000252	0.000649	CcSEcCtD
Vinorelbine—Vomiting—Brinzolamide—glaucoma	0.000252	0.000648	CcSEcCtD
Vinorelbine—Dizziness—Pilocarpine—glaucoma	0.000252	0.000648	CcSEcCtD
Vinorelbine—Headache—Travoprost—glaucoma	0.000251	0.000647	CcSEcCtD
Vinorelbine—Nausea—Brimonidine—glaucoma	0.000251	0.000645	CcSEcCtD
Vinorelbine—Feeling abnormal—Clonidine—glaucoma	0.000251	0.000645	CcSEcCtD
Vinorelbine—Rash—Brinzolamide—glaucoma	0.00025	0.000643	CcSEcCtD
Vinorelbine—Dermatitis—Brinzolamide—glaucoma	0.00025	0.000642	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00025	0.00231	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Clonidine—glaucoma	0.000249	0.00064	CcSEcCtD
Vinorelbine—Headache—Brinzolamide—glaucoma	0.000248	0.000639	CcSEcCtD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.000248	0.00229	CbGpPWpGaD
Vinorelbine—Hypotension—Betaxolol—glaucoma	0.000247	0.000637	CcSEcCtD
Vinorelbine—Angioedema—Timolol—glaucoma	0.000242	0.000623	CcSEcCtD
Vinorelbine—Vomiting—Pilocarpine—glaucoma	0.000242	0.000623	CcSEcCtD
Vinorelbine—Urticaria—Clonidine—glaucoma	0.000242	0.000622	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000241	0.000621	CcSEcCtD
Vinorelbine—Body temperature increased—Clonidine—glaucoma	0.00024	0.000619	CcSEcCtD
Vinorelbine—Abdominal pain—Clonidine—glaucoma	0.00024	0.000619	CcSEcCtD
Vinorelbine—Rash—Pilocarpine—glaucoma	0.00024	0.000618	CcSEcCtD
Vinorelbine—Dermatitis—Pilocarpine—glaucoma	0.00024	0.000617	CcSEcCtD
Vinorelbine—Nausea—Dorzolamide—glaucoma	0.000239	0.000616	CcSEcCtD
Vinorelbine—Headache—Pilocarpine—glaucoma	0.000239	0.000614	CcSEcCtD
Vinorelbine—Nausea—Travoprost—glaucoma	0.000238	0.000613	CcSEcCtD
Vinorelbine—Vertigo—Timolol—glaucoma	0.000238	0.000613	CcSEcCtD
Vinorelbine—Paraesthesia—Betaxolol—glaucoma	0.000238	0.000612	CcSEcCtD
Vinorelbine—Dyspnoea—Betaxolol—glaucoma	0.000236	0.000607	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—ACE2—glaucoma	0.000236	0.00218	CbGpPWpGaD
Vinorelbine—Nausea—Brinzolamide—glaucoma	0.000235	0.000606	CcSEcCtD
Vinorelbine—Palpitations—Timolol—glaucoma	0.000234	0.000603	CcSEcCtD
Vinorelbine—Cough—Timolol—glaucoma	0.000231	0.000595	CcSEcCtD
Vinorelbine—Decreased appetite—Betaxolol—glaucoma	0.00023	0.000592	CcSEcCtD
Vinorelbine—Hypertension—Timolol—glaucoma	0.000229	0.000589	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000229	0.000588	CcSEcCtD
Vinorelbine—Fatigue—Betaxolol—glaucoma	0.000228	0.000587	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000228	0.00211	CbGpPWpGaD
Vinorelbine—Pain—Betaxolol—glaucoma	0.000226	0.000583	CcSEcCtD
Vinorelbine—Constipation—Betaxolol—glaucoma	0.000226	0.000583	CcSEcCtD
Vinorelbine—Nausea—Pilocarpine—glaucoma	0.000226	0.000582	CcSEcCtD
Vinorelbine—Arthralgia—Timolol—glaucoma	0.000226	0.000581	CcSEcCtD
Vinorelbine—Chest pain—Timolol—glaucoma	0.000226	0.000581	CcSEcCtD
Vinorelbine—Myalgia—Timolol—glaucoma	0.000226	0.000581	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000224	0.000577	CcSEcCtD
Vinorelbine—Hypersensitivity—Clonidine—glaucoma	0.000224	0.000577	CcSEcCtD
Vinorelbine—Discomfort—Timolol—glaucoma	0.000223	0.000574	CcSEcCtD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000222	0.00205	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000222	0.00205	CbGpPWpGaD
Vinorelbine—Asthenia—Clonidine—glaucoma	0.000218	0.000561	CcSEcCtD
Vinorelbine—Feeling abnormal—Betaxolol—glaucoma	0.000218	0.000561	CcSEcCtD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000217	0.00201	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Timolol—glaucoma	0.000216	0.000557	CcSEcCtD
Vinorelbine—Pruritus—Clonidine—glaucoma	0.000215	0.000554	CcSEcCtD
Vinorelbine—Infection—Timolol—glaucoma	0.000215	0.000553	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000215	0.00198	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Timolol—glaucoma	0.000212	0.000546	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000211	0.00195	CbGpPWpGaD
Vinorelbine—Urticaria—Betaxolol—glaucoma	0.00021	0.000541	CcSEcCtD
Vinorelbine—Skin disorder—Timolol—glaucoma	0.00021	0.000541	CcSEcCtD
Vinorelbine—Body temperature increased—Betaxolol—glaucoma	0.000209	0.000539	CcSEcCtD
Vinorelbine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000208	0.00192	CbGpPWpGaD
Vinorelbine—Diarrhoea—Clonidine—glaucoma	0.000208	0.000535	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000208	0.00192	CbGpPWpGaD
Vinorelbine—Anorexia—Timolol—glaucoma	0.000206	0.000531	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000203	0.00188	CbGpPWpGaD
Vinorelbine—Hypotension—Timolol—glaucoma	0.000202	0.00052	CcSEcCtD
Vinorelbine—Dizziness—Clonidine—glaucoma	0.000201	0.000517	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Timolol—glaucoma	0.000197	0.000507	CcSEcCtD
Vinorelbine—Hypersensitivity—Betaxolol—glaucoma	0.000195	0.000502	CcSEcCtD
Vinorelbine—Paraesthesia—Timolol—glaucoma	0.000194	0.0005	CcSEcCtD
Vinorelbine—Vomiting—Clonidine—glaucoma	0.000193	0.000498	CcSEcCtD
Vinorelbine—Dyspnoea—Timolol—glaucoma	0.000193	0.000496	CcSEcCtD
Vinorelbine—Rash—Clonidine—glaucoma	0.000192	0.000493	CcSEcCtD
Vinorelbine—Dermatitis—Clonidine—glaucoma	0.000192	0.000493	CcSEcCtD
Vinorelbine—Headache—Clonidine—glaucoma	0.00019	0.00049	CcSEcCtD
Vinorelbine—Asthenia—Betaxolol—glaucoma	0.00019	0.000489	CcSEcCtD
Vinorelbine—Decreased appetite—Timolol—glaucoma	0.000188	0.000484	CcSEcCtD
Vinorelbine—Pruritus—Betaxolol—glaucoma	0.000187	0.000482	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Timolol—glaucoma	0.000187	0.00048	CcSEcCtD
Vinorelbine—Fatigue—Timolol—glaucoma	0.000186	0.00048	CcSEcCtD
Vinorelbine—Pain—Timolol—glaucoma	0.000185	0.000476	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000183	0.00169	CbGpPWpGaD
Vinorelbine—Diarrhoea—Betaxolol—glaucoma	0.000181	0.000466	CcSEcCtD
Vinorelbine—Nausea—Clonidine—glaucoma	0.000181	0.000465	CcSEcCtD
Vinorelbine—Feeling abnormal—Timolol—glaucoma	0.000178	0.000459	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Timolol—glaucoma	0.000177	0.000455	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND2—glaucoma	0.000175	0.00162	CbGpPWpGaD
Vinorelbine—Dizziness—Betaxolol—glaucoma	0.000175	0.000451	CcSEcCtD
Vinorelbine—Urticaria—Timolol—glaucoma	0.000172	0.000442	CcSEcCtD
Vinorelbine—Abdominal pain—Timolol—glaucoma	0.000171	0.00044	CcSEcCtD
Vinorelbine—Body temperature increased—Timolol—glaucoma	0.000171	0.00044	CcSEcCtD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000171	0.00158	CbGpPWpGaD
Vinorelbine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000171	0.00158	CbGpPWpGaD
Vinorelbine—Vomiting—Betaxolol—glaucoma	0.000168	0.000433	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000168	0.00155	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—PAX6—glaucoma	0.000167	0.00155	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—PAX6—glaucoma	0.000167	0.00155	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000167	0.00154	CbGpPWpGaD
Vinorelbine—Rash—Betaxolol—glaucoma	0.000167	0.00043	CcSEcCtD
Vinorelbine—Dermatitis—Betaxolol—glaucoma	0.000167	0.000429	CcSEcCtD
Vinorelbine—Headache—Betaxolol—glaucoma	0.000166	0.000427	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—PAX6—glaucoma	0.000162	0.00149	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Timolol—glaucoma	0.000159	0.00041	CcSEcCtD
Vinorelbine—Nausea—Betaxolol—glaucoma	0.000157	0.000405	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000157	0.00145	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND2—glaucoma	0.000157	0.00145	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—PAX6—glaucoma	0.000156	0.00145	CbGpPWpGaD
Vinorelbine—Asthenia—Timolol—glaucoma	0.000155	0.000399	CcSEcCtD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000154	0.00142	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—PAX6—glaucoma	0.000153	0.00141	CbGpPWpGaD
Vinorelbine—Pruritus—Timolol—glaucoma	0.000153	0.000394	CcSEcCtD
Vinorelbine—Diarrhoea—Timolol—glaucoma	0.000148	0.000381	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND2—glaucoma	0.000145	0.00134	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000144	0.00133	CbGpPWpGaD
Vinorelbine—Dizziness—Timolol—glaucoma	0.000143	0.000368	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CDKN2B—glaucoma	0.00014	0.0013	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000138	0.00127	CbGpPWpGaD
Vinorelbine—Vomiting—Timolol—glaucoma	0.000137	0.000354	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—PAX6—glaucoma	0.000137	0.00127	CbGpPWpGaD
Vinorelbine—Rash—Timolol—glaucoma	0.000136	0.000351	CcSEcCtD
Vinorelbine—Dermatitis—Timolol—glaucoma	0.000136	0.000351	CcSEcCtD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000136	0.00126	CbGpPWpGaD
Vinorelbine—Headache—Timolol—glaucoma	0.000135	0.000349	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND2—glaucoma	0.000133	0.00123	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.00013	0.0012	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND2—glaucoma	0.00013	0.0012	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—FAS—glaucoma	0.000129	0.00119	CbGpPWpGaD
Vinorelbine—Nausea—Timolol—glaucoma	0.000128	0.000331	CcSEcCtD
Vinorelbine—ABCB1—Allograft Rejection—C3—glaucoma	0.000127	0.00117	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—PAX6—glaucoma	0.000126	0.00116	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000119	0.0011	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND2—glaucoma	0.000119	0.0011	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2B—glaucoma	0.000116	0.00107	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTT1—glaucoma	0.000114	0.00105	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000112	0.00104	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000112	0.00103	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000109	0.001	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2B—glaucoma	0.000106	0.000983	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000104	0.00096	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MMP1—glaucoma	9.52e-05	0.00088	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MMP1—glaucoma	9.52e-05	0.00088	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MMP1—glaucoma	9.2e-05	0.00085	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	9.08e-05	0.000839	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2A—glaucoma	8.98e-05	0.000829	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	8.96e-05	0.000827	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP1—glaucoma	8.91e-05	0.000823	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP1—glaucoma	8.71e-05	0.000805	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA5A—glaucoma	8.48e-05	0.000783	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NARFL—glaucoma	8.48e-05	0.000783	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.1e-05	0.000749	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN2A—glaucoma	8.03e-05	0.000742	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NARFL—glaucoma	7.99e-05	0.000738	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA5A—glaucoma	7.99e-05	0.000738	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1B—glaucoma	7.95e-05	0.000735	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP1—glaucoma	7.82e-05	0.000722	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.47e-05	0.00069	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.45e-05	0.000688	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—glaucoma	7.44e-05	0.000687	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.42e-05	0.000686	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MMP2—glaucoma	7.37e-05	0.000681	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MMP2—glaucoma	7.37e-05	0.000681	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	7.36e-05	0.00068	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTM1—glaucoma	7.26e-05	0.000671	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	7.16e-05	0.000661	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP1—glaucoma	7.15e-05	0.000661	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MMP2—glaucoma	7.12e-05	0.000658	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1B—glaucoma	7.11e-05	0.000657	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.93e-05	0.000641	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP2—glaucoma	6.89e-05	0.000637	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—glaucoma	6.8e-05	0.000629	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP2—glaucoma	6.74e-05	0.000623	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2A—glaucoma	6.65e-05	0.000615	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1B—glaucoma	6.59e-05	0.000609	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—glaucoma	6.37e-05	0.000589	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.35e-05	0.000587	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—glaucoma	6.08e-05	0.000562	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP2—glaucoma	6.05e-05	0.000559	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1B—glaucoma	6.03e-05	0.000557	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	5.94e-05	0.000549	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1B—glaucoma	5.89e-05	0.000544	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	5.85e-05	0.000541	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP2—glaucoma	5.53e-05	0.000511	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—glaucoma	5.46e-05	0.000505	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.43e-05	0.000502	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1B—glaucoma	5.39e-05	0.000498	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NARFL—glaucoma	5.22e-05	0.000482	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA5A—glaucoma	5.22e-05	0.000482	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.08e-05	0.000469	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.75e-05	0.000439	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.68e-05	0.000432	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—glaucoma	4.47e-05	0.000413	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA1—glaucoma	4.14e-05	0.000382	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CTSA—glaucoma	4.01e-05	0.00037	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.99e-05	0.000369	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA1—glaucoma	3.9e-05	0.00036	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA2—glaucoma	3.79e-05	0.00035	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.78e-05	0.000349	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CTSA—glaucoma	3.78e-05	0.000349	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—glaucoma	3.7e-05	0.000342	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA2—glaucoma	3.57e-05	0.00033	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—glaucoma	3.39e-05	0.000313	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.15e-05	0.000291	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.7e-05	0.000249	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TXN—glaucoma	2.67e-05	0.000246	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA1—glaucoma	2.55e-05	0.000236	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TXN—glaucoma	2.51e-05	0.000232	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CTSA—glaucoma	2.47e-05	0.000228	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.38e-05	0.00022	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA2—glaucoma	2.33e-05	0.000216	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTT1—glaucoma	2.07e-05	0.000191	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTT1—glaucoma	1.95e-05	0.00018	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCA1—glaucoma	1.65e-05	0.000152	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1B1—glaucoma	1.65e-05	0.000152	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TXN—glaucoma	1.64e-05	0.000152	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1B1—glaucoma	1.55e-05	0.000143	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCA1—glaucoma	1.55e-05	0.000143	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—glaucoma	1.32e-05	0.000122	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTT1—glaucoma	1.27e-05	0.000118	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—glaucoma	1.24e-05	0.000115	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—glaucoma	1.16e-05	0.000108	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—glaucoma	1.1e-05	0.000101	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOE—glaucoma	1.08e-05	0.0001	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CAV1—glaucoma	1.07e-05	9.92e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOE—glaucoma	1.02e-05	9.44e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1B1—glaucoma	1.02e-05	9.38e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCA1—glaucoma	1.02e-05	9.38e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CAV1—glaucoma	1.01e-05	9.35e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NOS3—glaucoma	8.12e-06	7.5e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—glaucoma	8.12e-06	7.5e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NOS3—glaucoma	7.65e-06	7.07e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—glaucoma	7.43e-06	6.86e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—glaucoma	7.17e-06	6.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—glaucoma	7e-06	6.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOE—glaucoma	6.68e-06	6.17e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CAV1—glaucoma	6.62e-06	6.11e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NOS3—glaucoma	5e-06	4.62e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—glaucoma	4.58e-06	4.23e-05	CbGpPWpGaD
